English Program
Special Lecture
Special Lecture 1
15:20 - 16:00, Friday, October 1, 2021
Track 4
Pathophysiology of Microcirculation in Heart Failure
Sanjiv KAUL
(Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA)
Special Lecture 2
16:05 - 16:45, Friday, October 1, 2021
Track 4
How to tackle heart failure in ACHD patients: its unique physiology and treatment strategy
Lucy ROCHE
(University of Toronto, University Health Network - Toronto General Hospital, Canada)
Special Lecture 3
16:50 - 17:30, Friday, October 1, 2021
Track 4
Cardio-regenerative medicine using human stem cells
Timothy J. KAMP
(University of Wisconsin School of Medicine and Public Health, U.S.A.)
Special Lecture 4
9:10 - 9:50, Saturday, October 2, 2021
Track 2
New drugs for heart failure treatment; mechanisms and clinical evidence
Scott D. SOLOMON
(Senior Physician, Brigham and Womenʼs Hospital/Professor of Medicine, Harvard Medical School/Director, Noninvasive Cardiology, U.S.A.)
Special Lecture 6
15:15 - 15:55, Sunday, October 3, 2021
Track 1
New Insights of transcatheter intervention for congestive heart failure
Horst SIEVERT
(CardioVascular Center Frankfurt, Germany)
Joint Symposium
Joint Symposium 1
(Taiwan Society of Cardiology and Japanese Heart Failure Society Joint Symposium)
18:05 - 19:35, Saturday, October 2, 2021
Track 5
How to manage arrhythmias in patients with HF
| Chairs |
Hiroshi Morita Chii-Ming LEE |
|---|
JS1-1
Recent advances of medical therapy for preventing atrial fibrillation and sudden cardiac death in patients with heart failure
Chun-Chieh WANG
(Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital-Linkou, Guishan, Taoyuan, Taiwan)
JS1-2
Efficacy of catheter ablation for atrial fibrillation in patients with concomitant heart failure
Satoshi SHIZUTA
(Department of cardiovascular Medicine, Kyoto University Graduate School of Medicine)
JS1-3
Efficacy of catheter ablation for patients with lethal ventricular tachyarrhythmias and heart failure
Yenn-Jiang LIN
(National Yang Ming Chiao Tung University／Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan)
JS1-4
Device therapy for preventing cardiac sudden death in patients with heart failure
Nobuhiro NISHII
(Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences)
Joint Symposium 2
(Heart Failure Society of America, Heart Failure Association of the ESC and Japanese Heart Failure Society Joint Symposium)
7:45 - 9:15, Sunday, October 3, 2021
Track 2
New biomarkers to predict the prognosis of heart failure
| Chairs |
Yoshihiko SAITO Nancy M. ALBERT Andrew JS COATS |
|---|
JS2-1
Clinical congestion as a biomarker to assess prognosis in heart failure
Mark DRAZNER
(Heart Failure Society of America / University of Texas Southwestern Medical Center, Dallas, TX, U.S.A.)
JS2-2
Iron deficiency biomarkers to guide prognosis and therapy in heart failure
Stefan D ANKER
(Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin, Germany)
JS2-3
Risk Stratification of Heart Failure and Future Perspective
Toshihisa ANZAI
(Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine)
JS2-4
Biomarkers for Heart Failure Prognosis ~Based on Japanese nationwide HF database, JROADHF
Tomomi IDE
(Kyushu University, Department of Cardiovascular Medicine)
Joint Symposium 3
(Korean Society of Heart Failure and Japanese Heart Failure Society Joint Symposium)
14:05 - 15:35, Sunday, October 3, 2021
Track 6
How to manage super senior patients with HF
| Chairs |
Koichiro KUWAHARA Dong-Ju CHOI |
|---|
JS3-1
Characteristics of Heart Failure in the Older Population
Eung Ju KIM
(Division of Cardiology, Department of Medicine, Korea University Guro Hospital, Korea University College of Medicine, Republic of Korea)
JS3-2
Multi-domain frailty in elderly patients with heart failure
Yuya MATSUE
(Department of Biology and Cardiovascular Medicine, Juntendo University Graduate School of Medicine / Caradiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine)
JS3-3
How to optimize HF GDMT in super senior patients with HF
Seonghoon CHOI
(Division of Cardiololgy, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Republic of Korea)
JS3-4
Multidisciplinary approach for super senior patients with heart failure
Hirohiko MOTOKI
(Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Japan)
